micro-community-banner
  • Saved

3yr
The best and worst of times in therapy development for myasthenia gravis - PubMed

The best and worst of times in therapy development for myasthenia gravis - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/36321730/

Within the last 5 years the U.S. Federal Drug Administration (FDA) has approved complement and neonatal Fc receptor (FcRN)-inhibitors for treatment of generalized myasthenia gravis; and several other therapies are...


Relevance: The authors provide a summary of these discussions, but not a consensus opinion, and offer a series of recommendations to guide focused research in the most critical areas. We welcome ongoing discussion through comments on this publication.


  • Saved

3yr
A Heterozygous Mutation in MFF Associated with a Mild Mitochondrial Phenotype

A Heterozygous Mutation in MFF Associated with a Mild Mitochondrial Phenotype

Source : https://content.iospress.com/articles/journal-of-neuromuscular-diseases/jnd221532

You are viewing a javascript disabled version of the site. Please enable Javascript for this site to function properly. Go to header Go to navigation Go to search Go to...


Background:The number of mutations in nuclear encoded genes causing mitochondrial disease is ever increasing. Identification of these mutations is particularly important in the diagnosis of neuromuscular disorders as their presentation may mimic other acquired disorders.


  • Saved

3yr
Day 2 & 3 Highlights from the 2022 American Academy of Neurology Fall Conference

The American Academy of Neurology (AAN) 2022 Fall Conference featured the latest on diagnosing and treating dementia, epilepsy, movement disorders, headache, and other brain disorders, with content developed by neurologists for neurologists. The three-day hybrid AAN Fall Conference included in-person-only preconference programming for advanced practice providers plus a sports concussion workshop for general neurologists and subspecialists as well as anyone who treats sports injuries – specifically concussions – in their practice.

Click above for a summary of conference highlights.

  • Saved

3yr
Day 2 & 3 Highlights from the 2022 American Academy of Neurology Fall Conference

The American Academy of Neurology (AAN) 2022 Fall Conference featured the latest on diagnosing and treating dementia, epilepsy, movement disorders, headache, and other brain disorders, with content developed by neurologists for neurologists. The three-day hybrid AAN Fall Conference included in-person-only preconference programming for advanced practice providers plus a sports concussion workshop for general neurologists and subspecialists as well as anyone who treats sports injuries – specifically concussions – in their practice.



Click above for a summary of conference highlights.

 

  • Saved

3yr
Day 2 & 3 Highlights from the 2022 American Academy of Neurology Fall Conference

The American Academy of Neurology (AAN) 2022 Fall Conference featured the latest on diagnosing and treating dementia, epilepsy, movement disorders, headache, and other brain disorders, with content developed by neurologists for neurologists. The three-day hybrid AAN Fall Conference included in-person-only preconference programming for advanced practice providers plus a sports concussion workshop for general neurologists and subspecialists as well as anyone who treats sports injuries – specifically concussions – in their practice.

Click above for a summary of conference highlights.